Digital diagnostics, biomarkers and therapeutics in an evolving healthcare system: From promise to practice
British Journal of Clinical Pharmacology · 2026-07 · 92 (7) · 2016-2027
DOI: 10.1002/bcp.70527 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift British Journal of Clinical Pharmacology, online erschienen am 24.03.2026. Verfasst von Mees H P Stoop und 3 weiteren Autor:innen. Beteiligte Einrichtung: Juliana Children's Hospital, Haga Teaching hospital, The Hague, The Netherlands. Hauptthemen laut MEDLINE: Biomarkers, COVID-19, Delivery of Health Care. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Health care is shifting towards a digital‐guided system, integrating digital diagnostics, biomarkers and therapeutics in many care pathways. However, despite rapid technological advancement and preliminary adoption accelerated by the COVID‐19 pandemic, a significant implementation gap persists. This narrative review explores the causes of this gap, highlighting several examples from early development to final implementation. These show that technical validation alone is insufficient. Success depends on alignment with clinical need, robust external validation, patient empowerment and sustainable funding models. Furthermore, other systemic barriers include data privacy concerns and lack of transparency by commercial companies. To improve adoption and translate promise to practice, more international alignment of regulations and international collaboration is needed. Lessons must be learned from promising initiatives that did not reach clinical care, as much as from their successful counterparts. Ultimately, a comprehensive redesign of healthcare will be undertaken, with digital diagnostics and therapeutics both embedded as critical components rather than add‐ons. This demands a multi‐stakeholder effort involving governments, regulatory bodies, insurance providers, industry, research funders, hospital leadership, clinicians and, most importantly, patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Juliana Children's Hospital, Haga Teaching hospital, The Hague, The Netherlands.
- Department of Pedatrics, MosaKids Children's Hospital, Maastricht University Medical Center, Maastricht, The Netherlands.
- Department of Nephrology, Leiden University Medical Centre, Leiden, The Netherlands.
- Department of Pediatrics, Leiden University Medical Centre, Leiden, The Netherlands.
ORCID-Profile: Mees H P Stoop, Matthijs D Kruizinga
Zitieren
APA
Stoop, M. H. P., Driessen, G. J. A., Cohen, A. F., & Kruizinga, M. D. (2026). Digital diagnostics, biomarkers and therapeutics in an evolving healthcare system: From promise to practice. British Journal of Clinical Pharmacology, 92(7), 2016-2027. https://doi.org/10.1002/bcp.70527
Vancouver
Stoop MHP, Driessen GJA, Cohen AF, Kruizinga MD. Digital diagnostics, biomarkers and therapeutics in an evolving healthcare system: From promise to practice. British Journal of Clinical Pharmacology. 2026;92(7):2016-2027. doi:10.1002/bcp.70527
BibTeX
@article{Stoop2026,
author = {Stoop, Mees H P and Driessen, Gertjan J A and Cohen, Adam F and Kruizinga, Matthijs D},
title = {Digital diagnostics, biomarkers and therapeutics in an evolving healthcare system: From promise to practice},
journal = {British Journal of Clinical Pharmacology},
year = {2026},
volume = {92},
number = {7},
pages = {2016--2027},
doi = {10.1002/bcp.70527}
}
EUVIMED